Trends and burden of maternal disorders in China from 1990 to 2023: Analysis of the Global Burden of Disease Study 2023.

IF 9.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Chinese Medical Journal Pub Date : 2026-09-20 Epub Date: 2026-08-10 DOI:10.1097/CM9.0000000000004213
Juan Juan, Yunfei Liu, Chao Yang, Guohua He, Xinyu Shu, Huixia Yang
{"title":"Trends and burden of maternal disorders in China from 1990 to 2023: Analysis of the Global Burden of Disease Study 2023.","authors":"Juan Juan, Yunfei Liu, Chao Yang, Guohua He, Xinyu Shu, Huixia Yang","doi":"10.1097/CM9.0000000000004213","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Maternal morbidity and mortality are one of the key indicators of social development and are among the most challenging public health problems. This study aimed to analyze the trends and burden of maternal disorders in China from 1990 to 2023.</p><p><strong>Methods: </strong>The crude and age-standardized prevalence, mortality, and disability-adjusted life years (DALYs) for maternal disorders from 1990 to 2023 were analyzed using data on maternal disorders in China from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023. The changing trends of prevalence, mortality, and DALYs were evaluated by the average annual percentage change (AAPC) calculated using a log-transformed linear regression model. The ranks of the leading causes for maternal disorders in terms of prevalence, mortality, and DALYs in 1990, 2015, and 2023 were estimated to determine the impact of changes in the fertility strategy on maternal disorder patterns as China implemented the two-child policy in 2015.</p><p><strong>Results: </strong>In 2023, the age-standardized prevalence, mortality, and DALYs of maternal disorders among reproductive women aged 15-49 years in China were 193.04 (95% confidence interval [CI]: 192.56-193.54), 0.30 (95% CI: 0.28-0.32), and 27.78 (95% CI: 27.59-27.97) per 100,000 population, respectively. The prevalence showed a declining trend with fluctuations, and the mortality and DALYs both showed consistent decrease from 1990 to 2023, with AAPCs of -1.41% (95% CI: -1.92% to -0.90%), -10.64% (95% CI: -11.18% to -10.11%), and -9.37% (95% CI: -9.87% to -8.88%), respectively. In terms of the leading cause of death among the 10 available maternal disorders in GBD, maternal hemorrhage ranked first in 1990 (3.53 per 100,000) but decreased to third in 2015 (0.10 per 100,000) and 2023 (0.05 per 100,000). Among the 10 available maternal disorders in GBD 2023, the prevalence of maternal hypertensive disorders changed from first in 1990 to second both in 2015 and 2023. The other direct maternal disorders became the leading causes of prevalence and DALY during 2015 to 2023. Indirect maternal deaths ranked as the leading cause of mortality during 2015 to 2023.</p><p><strong>Conclusions: </strong>There has been a substantial decline in prevalence, mortality, and burden of maternal disorders in China during the past three decades. However, additional efforts are needed for decreasing the burden of maternal disorders, especially for maternal hypertensive disorders.</p>","PeriodicalId":10183,"journal":{"name":"Chinese Medical Journal","volume":" ","pages":"2741-2749"},"PeriodicalIF":9.1000,"publicationDate":"2026-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13593077/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Medical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/CM9.0000000000004213","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/10 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Maternal morbidity and mortality are one of the key indicators of social development and are among the most challenging public health problems. This study aimed to analyze the trends and burden of maternal disorders in China from 1990 to 2023.

Methods: The crude and age-standardized prevalence, mortality, and disability-adjusted life years (DALYs) for maternal disorders from 1990 to 2023 were analyzed using data on maternal disorders in China from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023. The changing trends of prevalence, mortality, and DALYs were evaluated by the average annual percentage change (AAPC) calculated using a log-transformed linear regression model. The ranks of the leading causes for maternal disorders in terms of prevalence, mortality, and DALYs in 1990, 2015, and 2023 were estimated to determine the impact of changes in the fertility strategy on maternal disorder patterns as China implemented the two-child policy in 2015.

Results: In 2023, the age-standardized prevalence, mortality, and DALYs of maternal disorders among reproductive women aged 15-49 years in China were 193.04 (95% confidence interval [CI]: 192.56-193.54), 0.30 (95% CI: 0.28-0.32), and 27.78 (95% CI: 27.59-27.97) per 100,000 population, respectively. The prevalence showed a declining trend with fluctuations, and the mortality and DALYs both showed consistent decrease from 1990 to 2023, with AAPCs of -1.41% (95% CI: -1.92% to -0.90%), -10.64% (95% CI: -11.18% to -10.11%), and -9.37% (95% CI: -9.87% to -8.88%), respectively. In terms of the leading cause of death among the 10 available maternal disorders in GBD, maternal hemorrhage ranked first in 1990 (3.53 per 100,000) but decreased to third in 2015 (0.10 per 100,000) and 2023 (0.05 per 100,000). Among the 10 available maternal disorders in GBD 2023, the prevalence of maternal hypertensive disorders changed from first in 1990 to second both in 2015 and 2023. The other direct maternal disorders became the leading causes of prevalence and DALY during 2015 to 2023. Indirect maternal deaths ranked as the leading cause of mortality during 2015 to 2023.

Conclusions: There has been a substantial decline in prevalence, mortality, and burden of maternal disorders in China during the past three decades. However, additional efforts are needed for decreasing the burden of maternal disorders, especially for maternal hypertensive disorders.

1990 - 2023年中国孕产妇疾病趋势与负担:全球疾病负担研究2023分析
背景:产妇发病率和死亡率是社会发展的关键指标之一,也是最具挑战性的公共卫生问题之一。本研究旨在分析1990 - 2023年中国孕产妇疾病的趋势和负担。方法:利用《全球疾病、伤害和危险因素负担研究(GBD) 2023》中的中国孕产妇疾病数据,分析1990 - 2023年孕产妇疾病的粗值和年龄标准化患病率、死亡率和残疾调整生命年(DALYs)。采用对数变换线性回归模型计算平均年变化百分比(AAPC)来评估患病率、死亡率和DALYs的变化趋势。通过对1990年、2015年和2023年孕产妇疾病主要原因的患病率、死亡率和DALYs排名进行估算,以确定2015年中国实施二孩政策后生育战略变化对孕产妇疾病模式的影响。结果:2023年,中国15-49岁育龄妇女孕产妇疾病的年龄标准化患病率、死亡率和DALYs分别为每10万人193.04(95%可信区间[CI]: 192.56-193.54)、0.30 (95% CI: 0.28-0.32)和27.78 (95% CI: 27.59-27.97)。患病率呈波动下降趋势,死亡率和DALYs从1990年到2023年均呈下降趋势,AAPCs分别为-1.41 (95% CI: -1.92 ~ -0.90)、-10.64 (95% CI: -11.18 ~ -10.11)和-9.37 (95% CI: -9.87 ~ -8.88)。就GBD中10种现有产妇疾病的主要死亡原因而言,产妇出血在1990年排名第一(每10万人中有3.53人死亡),但在2015年下降到第三(每10万人中有0.10人死亡)和2023年(每10万人中有0.05人死亡)。在GBD 2023中可选的10种孕产妇疾病中,孕产妇高血压疾病的患病率从1990年的第一位变为2015年和2023年的第二位。在2015年至2023年期间,其他直接孕产妇疾病成为患病率和伤残调整寿命的主要原因。2015年至2023年期间,孕产妇间接死亡是主要死亡原因。结论:在过去的30年里,中国孕产妇疾病的患病率、死亡率和负担都有了实质性的下降。然而,需要进一步努力减轻产妇疾病的负担,特别是产妇高血压疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Chinese Medical Journal
Chinese Medical Journal 医学-医学:内科
CiteScore
9.80
自引率
4.90%
发文量
19245
审稿时长
6 months
期刊介绍: The Chinese Medical Journal (CMJ) is published semimonthly in English by the Chinese Medical Association, and is a peer reviewed general medical journal for all doctors, researchers, and health workers regardless of their medical specialty or type of employment. Established in 1887, it is the oldest medical periodical in China and is distributed worldwide. The journal functions as a window into China’s medical sciences and reflects the advances and progress in China’s medical sciences and technology. It serves the objective of international academic exchange. The journal includes Original Articles, Editorial, Review Articles, Medical Progress, Brief Reports, Case Reports, Viewpoint, Clinical Exchange, Letter,and News,etc. CMJ is abstracted or indexed in many databases including Biological Abstracts, Chemical Abstracts, Index Medicus/Medline, Science Citation Index (SCI), Current Contents, Cancerlit, Health Plan & Administration, Embase, Social Scisearch, Aidsline, Toxline, Biocommercial Abstracts, Arts and Humanities Search, Nuclear Science Abstracts, Water Resources Abstracts, Cab Abstracts, Occupation Safety & Health, etc. In 2007, the impact factor of the journal by SCI is 0.636, and the total citation is 2315.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书